Pages that link to "Q37448971"
Jump to navigation
Jump to search
The following pages link to Insulin resistance in pulmonary arterial hypertension (Q37448971):
Displaying 50 items.
- Molecular pathogenesis of pulmonary arterial hypertension (Q24634317) (← links)
- Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training? (Q26781677) (← links)
- Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists (Q26860314) (← links)
- Targeting the Wnt signaling pathways in pulmonary arterial hypertension (Q27006826) (← links)
- Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension (Q27010531) (← links)
- Role of oxidized lipids in pulmonary arterial hypertension (Q28078566) (← links)
- Kidney dysfunction in patients with pulmonary arterial hypertension (Q33738621) (← links)
- Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? (Q33790168) (← links)
- Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension (Q33806024) (← links)
- Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension (Q33898213) (← links)
- Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension (Q34118474) (← links)
- Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 (Q34178976) (← links)
- Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man (Q34245617) (← links)
- Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report (Q34535086) (← links)
- Insulin resistance in pulmonary arterial hypertension, is it a novel disease modifier? (Q34621276) (← links)
- Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia (Q34782576) (← links)
- Pulmonary hypertension in women (Q34795939) (← links)
- An official American Thoracic Society Statement: pulmonary hypertension phenotypes (Q34919733) (← links)
- Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis (Q34992980) (← links)
- Pulmonary arterial dysfunction in insulin resistant obese Zucker rats (Q35035330) (← links)
- Unrecognized glucose intolerance is common in pulmonary arterial hypertension (Q35085796) (← links)
- Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner (Q35235680) (← links)
- O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension. (Q35328516) (← links)
- Impact of diabetes in patients with pulmonary hypertension (Q35517404) (← links)
- Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension (Q35835947) (← links)
- Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions? (Q35896190) (← links)
- The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension. (Q35975165) (← links)
- Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms (Q36228769) (← links)
- Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism (Q36421287) (← links)
- Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension (Q36490165) (← links)
- Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension (Q36568290) (← links)
- SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction (Q36614556) (← links)
- Updating clinical endpoint definitions. (Q36810813) (← links)
- Metabolic Dysfunction in Pulmonary Arterial Hypertension (Q36825335) (← links)
- Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension (Q36909329) (← links)
- Inhibition of fatty acid synthase is protective in pulmonary hypertension (Q36941262) (← links)
- A potential role for insulin resistance in experimental pulmonary hypertension (Q37104263) (← links)
- Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. (Q37434434) (← links)
- Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity (Q37591231) (← links)
- Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. (Q37596437) (← links)
- Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension. (Q37619276) (← links)
- Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension. (Q37642747) (← links)
- Which prognostic factors should be used in pulmonary arterial hypertension in elderly patients? (Q37670930) (← links)
- Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. (Q37688533) (← links)
- PPARgamma activation: a potential treatment for pulmonary hypertension (Q37725468) (← links)
- The role of mitochondria in pulmonary vascular remodeling (Q37782012) (← links)
- Update on pulmonary vascular diseases 2010. (Q37898899) (← links)
- The impact of current and novel anti-diabetic therapies on cardiovascular risk (Q38062033) (← links)
- Experimental and transgenic models of pulmonary hypertension. (Q38112056) (← links)
- Pulmonary arterial hypertension: challenges in translational research and a vision for change (Q38155079) (← links)